[1]Chen W,SZheng R,SZeng H,SZhang S. The updated incidences and mortalities of major cancers inSChina [J].Chin J Cancer,2015,34(11):502-507.中国临床肿瘤学会,中华血液学会,哈尔滨血液病肿瘤研究所.防治蒽环类抗肿瘤药物心脏毒性的中国专家共识[J].临床肿瘤学杂志,2011,16( 12) : 1122-1129. [2]Bayram C,S?etin ?,STavil B,SYarali N,et al. Evaluation ofScardiotoxicitySby tissue Doppler imaging in childhoodSleukemiaSsurvivors treated with low-dose anthracycline[J].Pediatr Cardiol,2015,36(4):862-866. [3]Walter RB,SOthus M,SBurnett AK,et.al. Significance ofSFABSsubclassification of "acute myeloidleukemia, NOS" in the 2008 WHO classification: analysis of 5848 newly diagnosed patients[J].Blood,2013,121(13):2424-2431. [4]万学红,卢雪峰.诊断学,第8版[M].北京,人民卫生出版社,2013:493-523. [5]Foresto SA,SYoulden DR,SBaade PD,et al. The outcomes andStreatmentSburden of childhood acute myeloidSleukaemiaSin Australia, 1997-2008: A report from the Australian Paediatric Cancer Registry[J]. Pediatr Blood Cancer, 2015,62(9):1664-1666. [6]Fan Y,SChen M,SMeng J,et al. Arsenic trioxide and resveratrol show synergistic anti-leukemia activity and neutralizedScardiotoxicity[J].PloS One,2014,9(8):e105890. [7]Wang H,SChi ZF,SLi S,et.al. Efficacy, side effects and blood concentration monitoring of high doseSmethotrexateSin treatment of 180 children with acute lymphoblastic leukemia[J]. Zhongguo Shi Yan Xue Ye Xue Za Zhi,2011,19(4):949-952. [8]Nelson-Veniard M,SThambo JB. Chemotherapy-inducedScardiotoxicity: Incidence, diagnosis and prevention[J]. Bull Cancer ,2015,102(7-8):622-6. [9]庞缨,陈军初,谢玮等.临床用药研究右丙亚胺对柔红霉素所致心脏毒性的防治作用[J].广东医学,2011,32( 12) : 1606-1607. [10]Pegram HJ1,SSmith EL1,SRafiq S1,Set al. CARStherapySfor hematological cancers: can success seen in theStreatmentSof B-cellSacute lymphoblastic leukemiaSbe applied to other hematological malignancies? [J]. Immunotherapy.S2015;7(5):545-61. [11]Inaba H1,SGreaves M,SMullighan CG. Acute lymphoblastic leukaemia[J]. Lancet.2013,381(9881):1943-55. [12]Van Dalen EC,Caron HN,Dickinson HO,et al.Cardioprotective interventions for cancer patients receiving anthracyclines[J].Cochrane Database Syst Rev,2011,15(6):3917. [13]Zerra P,SCochran TR,SFranco VI,et.al. An expert opinion on pharmacologic approaches to reducing theScardiotoxicitySof childhood acute lymphoblasticSleukemiaStherapies[J]. Expert Opin Pharmacother.S2013,14(11):1497-513.
|